"Cetirizine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
| Descriptor ID |
D017332
|
| MeSH Number(s) |
D03.383.606.515.200
|
| Concept/Terms |
Cetirizine- Cetirizine
- (2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic Acid
Zyrtec- Zyrtec
- Reactine
- Voltric
- Zirtek
|
Below are MeSH descriptors whose meaning is more general than "Cetirizine".
Below are MeSH descriptors whose meaning is more specific than "Cetirizine".
This graph shows the total number of publications written about "Cetirizine" by people in this website by year, and whether "Cetirizine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cetirizine" by people in Profiles.
-
Pityriasis rubra pilaris post-infection due COVID-19: case report. Colomb Med (Cali). 2021 Mar 18; 52(1):e7014577.
-
Urticaria as a first clinical manifestation of COVID-19. Eur J Dermatol. 2020 Dec 01; 30(6):737-738.
-
Dual-histamine receptor blockade with cetirizine - famotidine reduces pulmonary symptoms in COVID-19 patients. Pulm Pharmacol Ther. 2020 08; 63:101942.
-
Reposition of montelukast either alone or in combination with levocetirizine against SARS-CoV-2. Med Hypotheses. 2020 Nov; 144:110046.
-
Safe and effective intradermal influenza vaccine desensitization for delayed influenza vaccine allergy. Ann Allergy Asthma Immunol. 2018 06; 120(6):666-667.
-
Formulation and characterization of oral rapid disintegrating tablets of levocetirizine. Polim Med. 2018 Jan-Jun; 48(1):31-40.
-
Topical cetirizine 1% for treatment of androgenetic alopecia. Dermatol Ther. 2017 11; 30(6).
-
Cetirizine-responsive, persistent idiopathic eosinophilia in a nonatopic child. Ann Allergy Asthma Immunol. 2017 Feb; 118(2):230-231.
-
Clinicopathologic features of systemic contact dermatitis from ethylenediamine in cetirizine and levocetirizine. Dermatology. 2006; 213(4):353-5.
-
Recurrent acute hepatitis associated with use of cetirizine. Ann Pharmacother. 2004 Nov; 38(11):1844-7.